WG Biotech ApS 4
4 · Y-mAbs Therapeutics, Inc. · Filed Nov 29, 2023
Insider Transaction Report
Form 4
WG Biotech ApS
Director10% Owner
Transactions
- Purchase
Common Stock
2023-11-28$5.81/sh+30,671$178,275→ 4,373,392 total - Purchase
Common Stock
2023-11-27$5.49/sh+62,516$343,019→ 4,342,721 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $5.38 to $5.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $5.51 to $6.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.